Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration

Abstract

Tumor metastasis is a complex phenomenon that is the culmination of effects of numerous cellular factors. We have shown that the Epstein–Barr virus (EBV) oncoprotein, latent membrane protein 1 (LMP1), is capable of inducing a wide range of such factors in cell culture, expression of which is also elevated in the LMP1-expressing tumor, nasopharyngeal carcinoma (NPC), a highly invasive neoplasm. Recently, the membrane crosslinker protein, ezrin, has been implicated in tumor cell metastasis and malignant progression. In this study, we evaluated the possible role of LMP1 and ezrin in the pathophysiology of NPC. We show that C-terminal phosphorylation of ezrin is increased by the expression of LMP1 in nasopharyngeal (NP) cells through a protein kinase C (PKC) pathway. LMP1 enhances the organization of a ternary complex of CD44, ezrin and F-actin, which is a prerequisite for ezrin phosphorylation. In NPC tissues, the expression of phosphoezrin and LMP1 is directly correlated. Silencing of endogenously expressed ezrin suppresses LMP1-induced cell motility and invasiveness. Moreover, the inhibition of ezrin phosphorylation by PKC inhibitor suppresses migration and invasion of NP cells. These data show that the phosphorylation of ezrin and its recruitment to the cell membrane linked to F-actin and CD44 is a process required for LMP1-stimulated cell motility and invasion of NP cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Auvinen E, Kivi N, Vaheri A . (2007). Regulation of ezrin localization by Rac1 and PIPK in human epithelial cells. Exp Cell Res 313: 824–833.

    Article  CAS  Google Scholar 

  • Baumgartner M, Sillman AL, Blackwood EM, Srivastava J, Madson N, Schilling JW et al. (2006). The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc Natl Acad Sci USA 103: 13391–13396.

    Article  CAS  Google Scholar 

  • Bruce B, Khanna G, Ren L, Landberg G, Jirström K, Powell C et al. (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 24: 69–78.

    Article  CAS  Google Scholar 

  • Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A, Flores-Morales A . (2006). Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem 281: 29938–29948.

    Article  CAS  Google Scholar 

  • Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG . (1991). B cell phenotype-dependent expression of the Epstein–Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. J Gen Virol 72: 3025–3033.

    Article  CAS  Google Scholar 

  • Crepaldi T, Gautreau A, Comoglio PM, Louvard D, Arpin M . (1997). Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 138: 423–434.

    Article  CAS  Google Scholar 

  • Doi Y, Itoh M, Yonemura S, Ishihara S, Takano H, Noda T et al. (1999). Normal development of mice and unimpaired cell adhesion/cell motility/actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout. J Biol Chem 274: 2315–2321.

    Article  CAS  Google Scholar 

  • Fais S . (2004). A role for ezrin in a neglected metastatic tumor function. Trends Mol Med 10: 249–250.

    Article  CAS  Google Scholar 

  • Fievet BT, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D et al. (2004). Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 164: 653–659.

    Article  CAS  Google Scholar 

  • Gautreau A, Louvard D, Arpin M . (2002). ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol 14: 104–109.

    Article  CAS  Google Scholar 

  • Hiscox S, Jiang WG . (1999). Ezrin regulates cell–cell and cell–matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 112: 3081–3090.

    CAS  PubMed  Google Scholar 

  • Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A . (2007). Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Am J Physiol Gastrointest Liver Physiol 292: G806–G817.

    Article  CAS  Google Scholar 

  • Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T . (2001). Induction of c-Met proto-oncogene by Epstein–Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol 59: 27–33.

    Article  Google Scholar 

  • Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M et al. (2007). Twist and epithelial–mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970–1978.

    Article  CAS  Google Scholar 

  • Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A et al. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182–186.

    Article  CAS  Google Scholar 

  • Kondo S, Seo SY, Yoshizaki T, Wakisaka N, Furukawa M, Joab I et al. (2006). EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res 66: 9870–9877.

    Article  CAS  Google Scholar 

  • Kondo S, Wakisaka N, Schell MJ, Horikawa T, Sheen TS, Sato H et al. (2005). Epstein–Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 115: 368–376.

    Article  CAS  Google Scholar 

  • Kondo S, Yoshizaki T, Wakisaka N, Horikawa T, Murono S, Jang KL et al. (2007). MUC1 induced by Epstein–Barr virus latent membrane protein 1 causes dissociation of the cell–matrix interaction and cellular invasiveness via STAT signaling. J Virol 81: 1554–1562.

    Article  CAS  Google Scholar 

  • Larsson C . (2006). Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 18: 276–284.

    Article  CAS  Google Scholar 

  • Legg JW, Lewis CA, Parsons M, Ng T, Isacke CM . (2002). A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat Cell Biol 4: 399–407.

    Article  CAS  Google Scholar 

  • Lo KW, To KF, Huang DP . (2004). Focus on nasopharyngeal carcinoma. Cancer Cell 5: 423–428.

    Article  CAS  Google Scholar 

  • Louvet-VallĂ©e S . (2000). ERM proteins: from cellular architecture to cell signaling. Biol Cell 92: 305–316.

    Article  Google Scholar 

  • Martin TA, Harrison G, Mansel RE, Jiang WG . (2003). The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46: 165–186.

    Article  Google Scholar 

  • Miller WE, Mosialos G, Kieff E, Raab-Traub N . (1997). Epstein–Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol 71: 586–594.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M et al. (2001). Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98: 6905–6910.

    Article  CAS  Google Scholar 

  • Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A et al. (2001). Ezrin is a downstream effector of trafficking PKC–integrin complexes involved in the control of cell motility. Embo J 20: 2723–2741.

    Article  CAS  Google Scholar 

  • Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H . (2002). CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16: 3074–3086.

    Article  CAS  Google Scholar 

  • Park JH, Faller DV . (2002). Epstein–Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology 303: 345–363.

    Article  CAS  Google Scholar 

  • Raab-Traub N, Flynn K, Klein C, Pizza G, De Vinci C, Occhiuzzi L et al. (1987). EBV associated malignancies. J Exp Pathol 3: 449–456.

    CAS  PubMed  Google Scholar 

  • Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501.

    Article  CAS  Google Scholar 

  • Sun XG, Rotenberg SA . (1999). Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility. Cell Growth Differ 10: 343–352.

    CAS  PubMed  Google Scholar 

  • Takimoto T, Sato H, Ogura H, Tanaka S, Umeda R . (1988). The difference in tumorigenicity between Epstein–Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx. Laryngoscope 98: 1334–1338.

    Article  CAS  Google Scholar 

  • Tran Quang C, Gautreau A, Arpin M, Treisman R . (2000). Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J 19: 4565–4576.

    Article  CAS  Google Scholar 

  • Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP . (2002a). The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 12: 473–487.

    Article  CAS  Google Scholar 

  • Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z et al. (2002b). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590: 150–158.

    Article  CAS  Google Scholar 

  • Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M, Pagano JS . (2004). Epstein–Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 24: 5223–5234.

    Article  CAS  Google Scholar 

  • Wakisaka N, Murono S, Yoshizaki T, Furukawa M, Pagano JS . (2002). Epstein–Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res 62: 6337–6344.

    CAS  PubMed  Google Scholar 

  • Walter J, Schirrmacher V, Mosier D . (1995). Induction of CD44 expression by the Epstein–Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination. Int J Cancer 61: 363–369.

    Article  CAS  Google Scholar 

  • Yan G, Luo W, Lu Z, Luo X, Li L, Liu S et al. (2007). Epstein–Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway. Cell Signal 19: 341–348.

    Article  CAS  Google Scholar 

  • Yoshizaki T, Sato H, Furukawa M, Pagano JS . (1998). The expression of matrix metalloproteinase 9 is enhanced by Epstein–Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 95: 3621–3626.

    Article  CAS  Google Scholar 

  • Yoshizaki T, Wakisaka N, Pagano JS . (2005). Epstein–Barr virus, invasion and metastasis. In: Erle S. Robertson (ed). Epstein–Barr Virus, chapter 12. Caister Academic Press: Norfolk, pp 171–196.

    Google Scholar 

  • Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, Zha XL et al. (2006). The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 132: 685–697.

    Article  CAS  Google Scholar 

  • Zheng H, Li LL, Hu DS, Deng XY, Cao Y . (2007). Role of Epstein–Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4: 185–196.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Sai Wah Tsao and Erik K Flemington for the NP69SV40T cell line and the Ad-AH cell line, respectively. We thank Drs Yojiro Kotake and Yuki Okada for helpful advice. This work was supported by NCI (CA 19014) (JSP) and the Nakayama Foundation for Human Science (Tokyo, Japan) (KE).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J S Pagano.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endo, K., Kondo, S., Shackleford, J. et al. Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene 28, 1725–1735 (2009). https://doi.org/10.1038/onc.2009.20

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.20

Keywords

This article is cited by

Search

Quick links